Comparative assessment of hypotensive, metabolic, and endothelial effects of indapamide-retard and hydrochlorothiazide in patients with essential hypertension

Kardiologiya

Volumn 46, Issue 5, 2006, Pages 35-39

  Semenkin, A A ^a   Zhivilova, L A ^a   Golevtsova, Z Sh ^a   Protsky, I A ^a   Nazarov, A G ^a   Potapov, V V ^a   Pritykina, T V ^a  

^a OMSK STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Diuretics; Endothelial function; Hypertension; Metabolic effects

Indexed keywords

ANTIHYPERTENSIVE AGENT; HYDROCHLOROTHIAZIDE; INDAPAMIDE; TRIACYLGLYCEROL;

AGED; ARTICLE; BLOOD; BLOOD PRESSURE; BRACHIAL ARTERY; COMPARATIVE STUDY; DRUG EFFECT; ECHOGRAPHY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM; VASODILATATION;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD GLUCOSE; BLOOD PRESSURE; BRACHIAL ARTERY; ENDOTHELIUM, VASCULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; INDAPAMIDE; MALE; MIDDLE AGED; TREATMENT OUTCOME; TRIGLYCERIDES; VASODILATION;

EID: 33747163962     PISSN: 00229040     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Guidelines Committee. 2003 European Society of Hypertension - European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003;21:6:1011-1053.
2. Perticone F., Ceravolo R., Pujia A. et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 2001;104:191-196.
3. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. NIH Publication No 03-5233, May 2003.
4. Brook R.D. Mechanism of differential effects of antihypertensive agents on serum lipids. Curr Hyp Rep 2000;2:4:370-377.
5. Carbohydrate metabolism in hypertension: influence of treatment. J Cardiovasc Pharmacol 1993;22:Suppl 6:S87-S97.
6. Weidmann P. Metabolic profile of indapamide sustained-release in patients with hypertension: data from three randomised double-blind studies. Drug Saf 2001;24:15:1155-1165.
7. Kuo S.W., Hung Y.J., Hsieh A.T. et al. Effect of indapamide SR in the treatment of hypertensive patients with type 2 diabetes. Am J Hypertens 2003;16:8:623-628.
8. Wilson P.W., D'Agostino R.B., Levy D. et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:18:1837-1847.
9. Celermajer D.S., Sorensen K.E., Gooch V.M. et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:1111-1115.
10. Ames R.P. A comparison of blood lipid and blood pressure responses during the treatment of systemic hypertension with indapamide and with thiazides. Am J Cardiol 1996;22:77:6:12b-16b.
11. Sharabi Y., Grossman E., Nussinovitch N. et al. Indapamide - a substitute diuretic for hypertensives with hyperglycemia and/or dyslipidemia. Harefuah 1996;131:7/8:233-236, 295.
12. Zanchetti A., Crepaldi G., Bond G. et al. Effects of fosinopril and pravastatin on progression of asymptomatic carotid atherosclerosis in hypertension: results of the Plaque Hypertension Lipid lowering Italian Study (PHYLLIS). J Hypertens 2003;21:Suppl 4:S345.
13. Del Rio M., Chulia T., Merchan-Perez A. et al. Effects of indapamide on atherosclerosis development in cholesterol-fed rabbits. J Cardiovasc Pharmacol 1995;25:6:973-978.
14. Study of antiatherogenic properties of indapamide in a pharmacologic model. J Cardiovasc Pharmacol 1993;22:Suppl 6:S53-S56.
15. Schini V.B., Dewey J., Vanhoutte P.M. Effects of indapamide on endothelium-dependent relaxations in isolated canine femoral arteries. Am J Cardiol 1990;65:17:6H-10H.
16. Delbarre B., Delbarre G., Ferger A. Role of prostaglandins in the mechanism of action of indapamide. Arch Mal Coeur Vaiss 1990;83:8:1209-1212.
17. Boulanger C.M., Mombouli J.V., Vanhoutte P.M. Indapamide inhibits endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat. Fundam Clin Pharmacol 1993;7:8:443-448.
18. Lehoux S., Sirois M.G., Sirois P., Plante G.E. Acute and chronic diuretic treatment selectively affects vascular permeability in the unanesthetized normal rat. J Pharmacol Exp Ther 1994;269:3:1094-1099.
19. Muiesan M.L., Salvetti M., Monteduro C. et al. Effect of treatment on flow-dependent vasodilation of the brachial artery in essential hypertension. Hypertension 1999;33:1Pt:2:575-580.
20. Numabe A., Uehara Y., Hirawa N. et al. Effects of thiazide diuretic on vascular eicosanoid system of spontaneously hypertensive rats. J Hypertens 1989;7:6:493-499.
21. Calder J.A., Schachter M., Sever P.S. Vasorelaxant actions of 5-OH-indapamide, a major metabolite of indapamide: comparison with indapamide, hydrochlorothiazide and cicletanine. Eur J Pharmacol 1994;256:2:185-191.
22. Abrahams Z., Tan L.L., Pang M.Y. et al. Demonstration of an in vitro direct vascular relaxant effect of diuretics in the presence of plasma. J Hypertens 1996;14:3:381-388.
23. Colas B., Slama M., Massen H. et al. Direct vascular actions of methyclothiazide and indapamide in aorta of spontaneously hypertensive rats. Fundam Clin Pharmacol 2000;14:4:363-368.